About RDBCOV

HIPRA research vaccine RBDCOV Map

Recruitment forms

Participate in the clinical trial and helps to fulfil the purpose of the project: to offer a new tool to control the pandemic at short-medium and long term, and to manufacture and test the first recombinant protein-based vaccine to be authorised in Europe